Substantiation of the composition of a semi-solid dosage form with a probiotic component for use in dermatology
One of the important issues in the pharmaceutical development of a semisolid preparation for dermal use is the scientific and experimental justification for choosing the base-carrier of active substances. The aim of this study was to experimentally substantiate the choice of rational combination...
Guardado en:
Autores principales: | Alina Soloviova, Halyna Kukhtenko, Olha Kaliuzhnaia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Scientific Route OÜ
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b6e2813d39634c4d800465120bd00eb1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
HPLC DETERMINATION OF ETOPOSIDE IN INJECTABLE DOSAGE FORMS
por: MUNAWAR HAYAT,M, et al.
Publicado: (2011) -
DETERMINATION OF GABAPENTIN IN BULK DRUG AND IN PHARMACEUTICAL DOSAGE FORM BY HPLC METHOD
por: UDAYKUMAR RAO,B, et al.
Publicado: (2009) -
SIMULTANEOUS DETERMINATION OF ROSIGLITAZONE AND GLICLAZIDE IN PHARMACEUTICAL DOSAGE FORMS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
por: LAKSHMI,K.S, et al.
Publicado: (2010) -
Enhanced Skin Performance of Emulgel vs. Cream as Systems for Topical Delivery of Herbal Actives (Immortelle Extract and Hemp Oil)
por: Vanja M. Tadić, et al.
Publicado: (2021) -
Editorial: Probiotic Trigger Molecules in Action
por: Jasna Novak, et al.
Publicado: (2021)